# OnCo record rusfertide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rusfertide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rusfertide" ;
  schema:name "Rusfertide"@en ;
  schema:description "Rusfertide is the first drug to control polycythaemia vera's excess red cells by restricting iron, sparing patients repeated blood removal."@en ;
  schema:url <https://onco.cc/drugs/rusfertide/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Rusfertide> ;
  owl:sameAs <http://www.wikidata.org/entity/Q126717527> ;
  schema:citation <https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026> ;
  onco:status "approved" ;
  onco:tag "gap-fill" ;
  onco:modality "Hepcidin mimetic peptide" ;
  schema:alternateName "Mimrylo" ;
  onco:approval "US 2026: Erythrocytosis in adults with polycythaemia vera" ;
  onco:cancers <https://onco.cc/cancers/myeloproliferative-neoplasms/>, <https://onco.cc/cancers/polycythaemia-vera/> ;
  onco:technologies <https://onco.cc/technologies/peptide-drug-conjugate/> ;
  onco:companies <https://onco.cc/companies/takeda/> ;
  onco:trials <https://onco.cc/trials/verify/>, <https://onco.cc/trials/nct07648030/>, <https://onco.cc/trials/nct06033586/> .